ATE197817T1 - Prostatakrebs-gen - Google Patents

Prostatakrebs-gen

Info

Publication number
ATE197817T1
ATE197817T1 AT98960061T AT98960061T ATE197817T1 AT E197817 T1 ATE197817 T1 AT E197817T1 AT 98960061 T AT98960061 T AT 98960061T AT 98960061 T AT98960061 T AT 98960061T AT E197817 T1 ATE197817 T1 AT E197817T1
Authority
AT
Austria
Prior art keywords
prostate cancer
biallelic markers
methods
gene
relates
Prior art date
Application number
AT98960061T
Other languages
English (en)
Inventor
Daniel Cohen
Marta Blumenfeld
Ilya Chumakov
Lydie Bougueleret
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/996,306 external-priority patent/US5945522A/en
Application filed by Genset Sa filed Critical Genset Sa
Application granted granted Critical
Publication of ATE197817T1 publication Critical patent/ATE197817T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT98960061T 1997-12-22 1998-12-22 Prostatakrebs-gen ATE197817T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/996,306 US5945522A (en) 1997-12-22 1997-12-22 Prostate cancer gene
US9965898P 1998-09-09 1998-09-09
PCT/IB1998/002133 WO1999032644A2 (en) 1997-12-22 1998-12-22 Prostate cancer gene

Publications (1)

Publication Number Publication Date
ATE197817T1 true ATE197817T1 (de) 2000-12-15

Family

ID=26796342

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00115991T ATE236998T1 (de) 1997-12-22 1998-12-22 Prostatakrebs-gen
AT98960061T ATE197817T1 (de) 1997-12-22 1998-12-22 Prostatakrebs-gen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00115991T ATE236998T1 (de) 1997-12-22 1998-12-22 Prostatakrebs-gen

Country Status (11)

Country Link
US (1) US6346381B1 (de)
EP (1) EP0991770B1 (de)
JP (1) JP3889927B2 (de)
AT (2) ATE236998T1 (de)
AU (1) AU750183B2 (de)
CA (1) CA2311416A1 (de)
DE (2) DE69800415T2 (de)
DK (1) DK1052292T3 (de)
ES (1) ES2190925T3 (de)
PT (1) PT1052292E (de)
WO (1) WO1999032644A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105353B2 (en) 1997-07-18 2006-09-12 Serono Genetics Institute S.A. Methods of identifying individuals for inclusion in drug studies
CA2324869A1 (en) * 1998-04-09 1999-10-21 Whitehead Institute For Biomedical Research Biallelic markers
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
AU3438699A (en) * 1998-04-21 1999-11-08 Genset Biallelic markers for use in constructing a high density disequilibrium map of the human genome
CA2337694A1 (en) * 1998-08-07 2000-02-17 Genset S.A. Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof
US6825004B1 (en) 1998-08-07 2004-11-30 Genset S.A. Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
DE69920032T2 (de) 1998-11-10 2005-09-15 Genset Methoden, software und apparate zur identifizierung genomischer bereiche, die ein gen umfassen, das mit einem nachweisbaren merkmal assoziiert ist
CA2377468C (en) * 1999-07-27 2010-04-20 Phylos, Inc. Peptide acceptor ligation methods
CA2376361A1 (en) * 1999-08-19 2001-03-01 Genset S.A. Prostate cancer-related gene 3 (pg-3) and biallelic markers thereof
AU1358401A (en) * 1999-11-09 2001-06-06 Cell Therapeutics, Inc. Human lysophosphatidic acid acyltransferase-epsilon
US6562955B2 (en) * 2000-03-17 2003-05-13 Tosoh Corporation Oligonucleotides for detection of Vibrio parahaemolyticus and detection method for Vibrio parahaemolyticus using the same oligonucleotides
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US7567870B1 (en) 2000-07-31 2009-07-28 Institute For Systems Biology Multiparameter analysis for predictive medicine
US7993907B2 (en) * 2001-05-08 2011-08-09 Mowycal Lending, Llc Biochips and method of screening using drug induced gene and protein expression profiling
US7343247B2 (en) * 2001-07-30 2008-03-11 The Institute For Systems Biology Methods of classifying drug responsiveness using multiparameter analysis
US20040197845A1 (en) * 2002-08-30 2004-10-07 Arjang Hassibi Methods and apparatus for pathogen detection, identification and/or quantification
TWI340168B (en) 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
JP5629894B2 (ja) * 2004-12-07 2014-11-26 国立大学法人大阪大学 甲状腺乳頭癌を診断するための新規のマーカー
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US20090317799A1 (en) * 2005-05-18 2009-12-24 Decode Genetics Ehf. Variants at chr8q24.21 confer risk of cancer
AU2010245598A1 (en) * 2009-05-08 2011-11-17 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
US8741591B2 (en) 2009-10-09 2014-06-03 The Research Foundation For The State University Of New York pH-insensitive glucose indicator protein
JP6034782B2 (ja) 2010-05-25 2016-11-30 ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ Ｂａｍｂａｍ：ハイスループットシークエンシングデータの同時比較解析
US9646134B2 (en) 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
WO2013143698A1 (en) * 2012-03-27 2013-10-03 Curevac Gmbh Artificial nucleic acid molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459037A (en) 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5658730A (en) 1994-12-23 1997-08-19 Ctrc Research Foundation Methods of human prostate cancer diagnosis
US5861248A (en) 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US5925519A (en) 1996-06-03 1999-07-20 The Regents Of The University Of California Genetic alterations associated with prostate cancer

Also Published As

Publication number Publication date
DE69813302D1 (de) 2003-05-15
DE69813302T2 (de) 2003-12-11
EP0991770B1 (de) 2000-11-29
ES2190925T3 (es) 2003-09-01
WO1999032644A3 (en) 1999-09-10
ATE236998T1 (de) 2003-04-15
DE69800415D1 (de) 2001-01-04
US6346381B1 (en) 2002-02-12
PT1052292E (pt) 2003-06-30
AU750183B2 (en) 2002-07-11
JP3889927B2 (ja) 2007-03-07
WO1999032644A2 (en) 1999-07-01
CA2311416A1 (en) 1999-07-01
DE69800415T2 (de) 2001-07-19
JP2002516657A (ja) 2002-06-11
AU1574099A (en) 1999-07-12
EP0991770A2 (de) 2000-04-12
DK1052292T3 (da) 2003-07-28

Similar Documents

Publication Publication Date Title
DK1052292T3 (da) Prostatacancer-gen
White et al. Genetic association of physically unlinked islands of genomic divergence in incipient species of Anopheles gambiae
Cubells et al. Population genetics of a functional variant of the dopamine β‐hydroxylase gene (DBH)
WO1990013668A1 (en) Method for genetic analysis of a nucleic acid sample
Yin et al. Multiple single nucleotide polymorphisms on human chromosome 19q13. 2–3 associate with risk of Basal cell carcinoma
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
Lee et al. Genetic characteristics and population study of 4 X-chromosomal STRs in Koreans: evidence for a null allele at DXS9898
Petkovski et al. SNPs and MALDI-TOF MS: tools for DNA typing in forensic paternity testing and anthropology
DE60041912D1 (de) Polymorphe marker des lsr-gens
US20210180128A1 (en) Method to confirm variants in ngs panel testing by snp genotyping
US5773649A (en) DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells
ATE397064T1 (de) Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
Nakamura et al. Simple and accurate determination of CYP2D6 gene copy number by a loop-mediated isothermal amplification method and an electrochemical DNA chip
Sanchez et al. Duplications of the Y-chromosome specific loci P25 and 92R7 and forensic implications
Bonk et al. Molecular diagnosis of familial adenomatous polyposis (FAP): genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry
Shen et al. Improved detection of global copy number variation using high density, non-polymorphic oligonucleotide probes
ATE408025T1 (de) Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen
Sánchez-García et al. Multiplex fluorescent analysis of four short tandem repeats for rapid haemophilia A molecular diagnosis
ATE315104T1 (de) Glaukom diagnose und behandlung
Park et al. Presymptomatic diagnosis of familial adenomatous polyposis coli
Jeffreys et al. “Major minisatellite loci” detected by minisatellite clones 33.6 and 33.15 correspond to the cognate loci D1S111 and D7S437
Mitra et al. Haplotype structure of TP53 locus in Indian population and possible association with head and neck cancer
Ząbek et al. Epigenetic structure and the role of polymorphism in the shaping of DNA methylation patterns of equine OAS1 locus
Süzen et al. Molecular analysis of δ-aminolevulinic acid dehydratase (ALAD) gene polymorphism in a Turkish population

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification